title: Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients.
abstract: BACKGROUND
  Host genetic factors may be important in determining not only disease susceptibility, but also disease behaviour and response to therapy in inflammatory bowel disease. Two polymorphisms (C3435T and G2677T/A) of the multidrug resistance 1 gene have been correlated with the altered P-glycoprotein expression and function in humans, and associated with predisposition to ulcerative colitis and Crohn's disease.
  
  
  OBJECTIVE
  To investigate the contribution of these polymorphisms to disease susceptibility and response to medical therapy.
  
  
  METHODS
  A total of 946 inflammatory bowel disease patients (478 Crohn's disease, 272 males, mean age 43 +/- 14 years and 468 ulcerative colitis, 290 males, mean age 48 +/- 15 years) and 450 healthy controls were genotyped for the single nucleotide polymorphisms C3435T and G2677T/A. Patients were also classified on the basis of response to medical therapy (mesalazine, steroids, immunosuppressives and infliximab).
  
  
  RESULTS
  Both single nucleotide polymorphisms were in Hardy-Weinberg equilibrium and significant linkage disequilibrium. No significant difference in the allele, genotype, and haplotype frequencies was found in both Crohn's disease and ulcerative colitis patients compared with the controls. No correlation with clinical features was found, except for a reduced frequency of extra-intestinal manifestations in Crohn's disease patients with the G2677T genotype (40%) compared with GG2677 and 2677TT genotypes (54% and 58%, respectively) (P = <0.02). No significant difference was also found after stratifying the patients on the basis of their response to medical therapy.
  
  
  CONCLUSIONS
  The investigated polymorphisms of the multidrug resistance 1 gene have no significant role in disease susceptibility and response to medical therapy in our Italian population of inflammatory bowel disease patients.
authors.affiliation: U.O. Gastroenterologia, Ospedale CSS-IRCCS, San Giovanni Rotondo, Italy.
authors.forename: O
authors.initials: O
authors.lastname: Palmieri
authors.forename: A
authors.initials: A
authors.lastname: Latiano
authors.forename: R
authors.initials: R
authors.lastname: Valvano
authors.forename: R
authors.initials: R
authors.lastname: D'Incà
authors.forename: M
authors.initials: M
authors.lastname: Vecchi
authors.forename: G C
authors.initials: GC
authors.lastname: Sturniolo
authors.forename: S
authors.initials: S
authors.lastname: Saibeni
authors.forename: F
authors.initials: F
authors.lastname: Bossa
authors.forename: T
authors.initials: T
authors.lastname: Latiano
authors.forename: M
authors.initials: M
authors.lastname: Devoto
authors.forename: A
authors.initials: A
authors.lastname: Andriulli
authors.forename: V
authors.initials: V
authors.lastname: Annese
mesh_terms: D016022:Case-Control Studies; D005260:Female; D019450:Genes, MDR / Q000235:genetics*; D005838:Genotype; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*